Abacus Life, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Abacus Life, Inc. (formerly Abacus Global Management, Inc.) on February 13, 2024. The registrant is an emerging growth company incorporated in Delaware. The report details the Board of Directors' approval of the 2024 annual incentive plan and the granting of long-term equity awards to named executive officers.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation structures and equity grant details.
Material Changes and Compensation Details
The Board approved the following compensation arrangements for 2024:
- Annual Incentive Plan: Named executive officers may earn an annual bonus ranging from 50% to 200% of their 2024 beginning base salary, contingent on achieving Adjusted EBITDA growth targets. Individual performance may adjust the bonus by up to 10%. The payout mix may range from 25% to 100% cash, with the remainder in equity.
- Long-Term Equity Awards: Grants were made under the 2023 Long-Term Equity Compensation Incentive Plan, vesting equally over three years.
- Restricted Stock Units (RSUs): 24,000 units each to Messrs. Jackson and McNealy; 12,000 units to Mr. McCauley.
- Stock Options: 76,725 options each to Messrs. Jackson and McNealy; 38,363 options to Mr. McCauley. Options have a 10-year term and an exercise price based on the closing price on February 12, 2024.
- Vesting Conditions: Awards require continued employment through the vesting period. Prorated awards apply for involuntary termination without cause, death, disability, or retirement. Full acceleration occurs upon a change in control.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, market outlook, or specific risk factors beyond standard compensation plan terms. The primary contingency noted is the requirement for Adjusted EBITDA growth targets to be met for bonus eligibility.
Key Facts for Investor Verification
- Verify the specific Adjusted EBITDA growth targets required to trigger the 50% to 200% bonus range.
- Confirm the exact exercise price of the stock options granted on February 12, 2024.
- Review the Company's 2023 Long-Term Equity Compensation Incentive Plan for detailed definitions of "change in control" and termination scenarios.
- Monitor future filings for the actual payout mix (cash vs. equity) determined for the 2024 bonus cycle.